In addition to traditional LASIK capabilities to treat myopia (nearsightedness), hyperopia (farsightedness) and astigmatism, the TENEO 317 has integrated SUPRACOR™, a corneal approach to treating presbyopia. Presbyopia, caused by the natural course of aging, is a gradual thickening and loss of flexibility of the natural lens inside the eye making it harder to focus up close. SUPRACOR is a special procedure designed to provide presbyopia correction, while minimizing the induction of unwanted aberrations within the pupil region.
"Our new TENEO 317 laser is simple and highly intuitive to use, incorporating our fastest, next generation eyetracker technology. The system features advanced ergonomics and a compact footprint, allowing it to easily integrate into any practice," said
About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people's eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments. We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.
®/™ are trademarks of
© 2013 Bausch & Lomb Incorporated.
News Media Contacts:
Lindsay Brooks Medical CommunicationsBausch + Lomb Technolas +44 7825 769 007 (mobile) Email Contact